~ariana-pharma
What is the LYRICAN program of excellence for cancer research?
What is Professor Blay's current role at the European Society for Medical Oncology (ESMO)?
Does KEM® perform optimization of binning boundaries towards a given endpoint?
How are 'real world patients' different from patients enrolled in clinical trials?
What expertise does Professor Jacques Touchon bring to Ariana Pharma?
What research cooperative groups and networks is Professor Blay managing?
What is the role of Professor Jean-Yves Blay in Ariana Pharma?
How can real world controls help in regulatory decision-making?
What is the purpose of Ariana's cloud analytics and reporting platform?
What medical need does the AugmenTreg project address?
What criteria are used for ranking and filtering in KEM®?
What breakthrough has been made in identifying survival biomarkers across various cancer types?
What is Onco KEM® and what does it do?
What is the potential of high quality curated electronic health records (EHR) data collected during routine clinical care of patients?
Who was appointed to Ariana Pharma's Scientific Advisory Board?
